An Association Study of ESR1–XbaI and PvuII Gene Polymorphism in Migraine Susceptibility in the Jammu Region

Clinical Neurology: Research Article

Kumar S.a· Raina J.K.c· Sudershan A.b,d· Mahajan K.b· Jasrotia R.a· Maharana C.a· Panjalia R.K.a· Kumar P.a,b

Author affiliations

aDepartment of Zoology, University of Jammu, Jammu, India
bInstitute of Human Genetics, University of Jammu, Jammu, India
cDepartment of Human Genetics, Govt. Gandhi Memorial Science College, Cluster University of Jammu, Jammu, India
dDepartment of Human Genetics, Sri Pratap College Srinagar, Cluster University of Srinagar, Kashmir, India

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Abstract of Clinical Neurology: Research Article

Received: May 27, 2022
Accepted: September 21, 2022
Published online: November 25, 2022

Number of Print Pages: 8
Number of Figures: 3
Number of Tables: 6

ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)

For additional information: https://www.karger.com/ENE

Abstract

Introduction: Migraine is a neurovascular disorder and is clinically characterized by episodic attacks of mild to severe headaches. Due to the involvement of multiple environmental and genetic factors, it has become a much more complex neurological condition to understand. Apart from the environmental variables, a plethora of genes have been implicated, and one such example is ESR1. The present study was focused to find out the association of two important polymorphisms, namely, PvuII and XbaI of the ESR1 with migraine in the population of Jammu and Kashmir (UT). Methods: The PCR-RFLP genotyping method was utilized to detect PvuII and XbaI polymorphism, and the result was confirmed by statistical analysis. Results: Although we did not find a signification association of ESR-PvuII polymorphism with migraine susceptibility , a strong association was found with the clinical subtype of migraine; migraine with aura (MA) . Furthermore, a significant association of ESR-XbaI polymorphism was observed with migraine and MA . Conclusion: In conclusion, ESR1-XbaI polymorphism is significantly associated with migraine risk including both subtypes (MA and MO) in the North Indian population of Jammu.

© 2022 S. Karger AG, Basel

References Russell MB, Hilden J, Sørensen SA, Olesen J. Familial occurrence of migraine without aura and migraine with aura. Neurology. 1993 Jul 1;43(7):1369–73. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population—a prevalence study. J Clin Epidemiol. 1991 Jan 1;44(11):1147–57. Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012 Feb;16(1):86–92. Leao AAP. Further observations on the spreading depression of activity in the cerebral cortex. J Neurophysiol. 1947 Nov;10(6):409–14. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002 Feb;8(2):136–42. Ramachandran R. Neurogenic inflammation and its role in migraine. Semin Immunopathol. 2018 May;40(3):301–14. Spekker E, Laborc KF, Bohár Z, Nagy-Grócz G, Fejes-Szabó A, Szűcs M, et al. Effect of dural inflammatory soup application on activation and sensitization markers in the caudal trigeminal nucleus of the rat and the modulatory effects of sumatriptan and kynurenic acid. J Headache Pain. 2021 Dec;22(1):17. Andreou AP, Edvinsson L. Mechanisms of migraine as a chronic evolutive condition. J Headache Pain. 2019 Dec;20(1):117. Sudershan A, Mahajan K, Singh K, Dhar MK, Kumar P. The complexities of migraine: a debate among migraine researchers: a review. Clin Neurol Neurosurg. 2022 Mar 1;214:107136. MacGregor EA. “Menstrual” migraine: towards a definition. Cephalalgia. 1996 Feb;16(1):11–21. MacGregor EA. Menstruation, sex hormones, and migraine. Neurol Clin. 1997 Feb 1;15(1):125–41. Österlund MK, Grandien K, Keller E, Hurd YL. The human brain has distinct regional expression patterns of estrogen receptor α mRNA isoforms derived from alternative promoters. J Neurochem. 2002;75(4):1390–7. Cenni B, Picard D. Ligand-independent activation of steroid receptors: new roles for old players. Trends Endocrinol Metab. 1999 Mar 1;10(2):41–6. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999 Feb 1;103(3):401–6. Luconi M, Forti G, Baldi E. Genomic and nongenomic effects of estrogens: molecular mechanisms of action and clinical implications for male reproduction. J Steroid Biochem Mol Biol. 2002 Apr 1;80(4–5):369–81. He M, Shu J, Huang X, Tang H. Association between estrogen receptora gene (ESR1) PvuII (T/C) and XbaI (A/G) polymorphisms and premature ovarian failure risk: evidence from a meta-analysis. J Assist Reprod Genet. 2015 Feb;32(2):297–304. Russell DW, Sambrook J. Molecular cloning: a laboratory manual. NY: Cold Spring HarborCold Spring Harbor Laboratory; 2001. Meshkani R, Saberi H, MohammadTaghvaei N, Tabatabaiefar MA. Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects. Mol Cell Biochem. 2012 Jan;359(1–2):225–33. Ghosh J, Joshi G, Pradhan S, Mittal B. Potential role of aromatase over estrogen receptor gene polymorphisms in migraine susceptibility: a case control study from North India. PloS One. 2012 Apr 12;7(4):e34828. Li L, Liu R, Dong Z, Wang X, Yu S. Impact of ESR1 gene polymorphisms on migraine susceptibility: a meta-analysis. Medicine. 2015 Sep;94(35):e0976. Wang YM, Liu ZW, Guo JB, Wang XF, Zhao XX, Zheng X. ESR1 gene polymorphisms and prostate cancer risk: a HuGE review and meta-analysis. PloS One. 2013 Jun 21;8(6):e66999. Arslan HS, Nursal AF, Inanir A, Karakus N, Yigit S. Influence of ESR1 variants on clinical characteristics and Fibromyalgia syndrome in Turkish women. Endocr Metab Immune Disord Drug Targets. 2021 Jul 1;21(7):132632. Lee YH, Song GG. Estrogen receptor 1 PvuII and XbaI polymorphisms and susceptibility to Alzheimer’s disease: a meta-analysis. Genet Mol Res. 2015 Aug 10;14(3):9361–9. Clapauch R, Mourao AF, Mecenas AS, Maranhao PA, Rossini A, Bouskela E. Endothelial function and insulin resistance in early postmenopausal women with cardiovascular risk factors: importance of ESR1 and NOS3 polymorphisms. PLoS One. 2014 Jul 31;9(7):e103444. Article / Publication Details

First-Page Preview

Abstract of Clinical Neurology: Research Article

Received: May 27, 2022
Accepted: September 21, 2022
Published online: November 25, 2022

Number of Print Pages: 8
Number of Figures: 3
Number of Tables: 6

ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)

For additional information: https://www.karger.com/ENE

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

留言 (0)

沒有登入
gif